Ross Moat
CHIEF OPERATING OFFICER · 3 filings · Latest: Apr 9, 2026
Kiniksa Pharmaceuticals International, plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
KNSA | Ross Moat | CHIEF OPERATING OFFICER | Apr 9, 2026 | Sale | $46.69 | 1,703 | $79.5K | 12,029 | |
KNSA | Ross Moat | CHIEF OPERATING OFFICER | Apr 7, 2026 | Tax Withholding | $48.94 | 774 | $37.9K | 13,732 | |
KNSA | Ross Moat | CHIEF OPERATING OFFICER | Apr 7, 2026 | Option Exercise | — | 2,477 | — | 14,506 | |
KNSA | Ross Moat | CHIEF OPERATING OFFICER | Apr 6, 2026 | Sale | $48.58 | 2,367 | $115.0K | 12,029 | |
KNSA | Ross Moat | CHIEF OPERATING OFFICER | Apr 1, 2026 | Tax Withholding | $48.13 | 1,706 | $82.1K | 14,396 | |
KNSA | Ross Moat | CHIEF OPERATING OFFICER | Apr 1, 2026 | Option Exercise | — | 5,808 | — | 16,102 | |
KNSA | Ross Moat | CHIEF OPERATING OFFICER | Jan 15, 2026 | Grant/Award | $24.16 | 879 | $21.2K | 10,294 |